To include your compound in the COVID-19 Resource Center, submit it here.

IV G1T28-1: Phase I started

G1 began a double-blind, placebo-controlled, Dutch Phase I trial to

Read the full 108 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE